YAP1 and cancer: As the two pathways have been reported as key regulators of cancers, inflammation, and lipid metabolism [9, 47–50], loss of miR-122 may lead to activate YAP/TAZ-TEAD transcriptional networks that promote cell proliferation and largely increase the liver tumor incidence driven by a chronic aseptic inflammation.